enow.com Web Search

  1. Ads

    related to: new treatment for migraine headaches medications

Search results

  1. Results from the WOW.Com Content Network
  2. FDA approves Pfizer's new nasal spray treatment for migraines

    www.aol.com/news/fda-approves-pfizers-nasal...

    The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.

  3. This New Nasal Spray Could Provide Migraine Relief in ... - AOL

    www.aol.com/lifestyle/nasal-spray-could-migraine...

    Zavzpret is a new nasal spray to treat migraine headaches in adults. But how does the medication work and who should try the new FDA-approved medication?

  4. Academics said their findings are ‘important’ considering the higher costs of new treatments. New migraine drugs ‘comparable to paracetamol’, researchers suggest Skip to main content

  5. Management of migraine - Wikipedia

    en.wikipedia.org/wiki/Management_of_migraine

    Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...

  6. Antimigraine drug - Wikipedia

    en.wikipedia.org/wiki/Antimigraine_drug

    Examples of specific antimigraine drug classes include triptans (first line option), ergot alkaloids, ditans and gepants. Migraines can also be treated with unspecific analgesics such as nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen. Opioids are not recommended for treatment of migraines.

  7. Migraine - Wikipedia

    en.wikipedia.org/wiki/Migraine

    In 2018, the first medication of a new class of drugs specifically designed for migraine prevention called calcitonin gene-related peptide receptor antagonists (CGRPs) was approved by the FDA. [20] As of July 2023, the FDA has approved eight drugs that act on the CGRP system for use in the treatment of migraine. [21]

  1. Ads

    related to: new treatment for migraine headaches medications